Modification of blood group A antigen expression in a pancreatic cancer cell line (PC‐1) by inhibitors of N‐glycan processing

Masahiko Hirota, Masatoshi Mogaki, Parviz M. Pour, William G Chaney

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Pancreatic adenocarcinomas induced in Syrian hamsters by treatment with N‐nitrosobis(2‐oxopropyl) amine express blood group A antigen, which is absent in normal pancreatic cells. On membrane glycoproteins purified from tumors, blood group A antigen has been found to be expressed on multiantennary Asn‐linked complex glycans. In this study, we investigated the effect of inhibitors of Asn‐glycan processing on blood group A antigen bearing glycan structures in a cell line (PC‐1) established from a primary induced pancreatic cancer. Expression of blood group A antigen on cells and in membrane preparations was blocked by treatment with 1‐deoxymannojirimycin, an inhibitor of mannosidase I, but was retained after treatment with swainsonine, an inhibitor of mannosidase II. However, swainsonine treatment altered the glycan structure associated with blood group A antigen from an endoglycosidase H resistant type to a sensitive type, indicating that the blood group A structure might shift from a complex type to a hybr‐id type glycan by this treatment. These results demonstrate that Asn‐linked glycans carry the major blood group A antigens in PC‐1 cells. © 1992 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)13-20
Number of pages8
JournalJournal of Cellular Biochemistry
Volume50
Issue number1
DOIs
StatePublished - Jan 1 1992

Fingerprint

Blood Group Antigens
Pancreatic Neoplasms
Cells
Antigens
Cell Line
Polysaccharides
Processing
Swainsonine
mannosyl-oligosaccharide 1,2-alpha-mannosidase
Bearings (structural)
Glycoside Hydrolases
Mesocricetus
Membrane Glycoproteins
Amines
Tumors
Adenocarcinoma
Cell Membrane
Membranes
Neoplasms

Keywords

  • 1‐deoxymannojirimycin
  • Asn‐linked glycan
  • blood group A antigen
  • pancreatic cancer cell line
  • swainsonine

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Modification of blood group A antigen expression in a pancreatic cancer cell line (PC‐1) by inhibitors of N‐glycan processing. / Hirota, Masahiko; Mogaki, Masatoshi; Pour, Parviz M.; Chaney, William G.

In: Journal of Cellular Biochemistry, Vol. 50, No. 1, 01.01.1992, p. 13-20.

Research output: Contribution to journalArticle

Hirota, Masahiko ; Mogaki, Masatoshi ; Pour, Parviz M. ; Chaney, William G. / Modification of blood group A antigen expression in a pancreatic cancer cell line (PC‐1) by inhibitors of N‐glycan processing. In: Journal of Cellular Biochemistry. 1992 ; Vol. 50, No. 1. pp. 13-20.
@article{7754cb0ef6524f44b1845e2fb2ca9672,
title = "Modification of blood group A antigen expression in a pancreatic cancer cell line (PC‐1) by inhibitors of N‐glycan processing",
abstract = "Pancreatic adenocarcinomas induced in Syrian hamsters by treatment with N‐nitrosobis(2‐oxopropyl) amine express blood group A antigen, which is absent in normal pancreatic cells. On membrane glycoproteins purified from tumors, blood group A antigen has been found to be expressed on multiantennary Asn‐linked complex glycans. In this study, we investigated the effect of inhibitors of Asn‐glycan processing on blood group A antigen bearing glycan structures in a cell line (PC‐1) established from a primary induced pancreatic cancer. Expression of blood group A antigen on cells and in membrane preparations was blocked by treatment with 1‐deoxymannojirimycin, an inhibitor of mannosidase I, but was retained after treatment with swainsonine, an inhibitor of mannosidase II. However, swainsonine treatment altered the glycan structure associated with blood group A antigen from an endoglycosidase H resistant type to a sensitive type, indicating that the blood group A structure might shift from a complex type to a hybr‐id type glycan by this treatment. These results demonstrate that Asn‐linked glycans carry the major blood group A antigens in PC‐1 cells. {\circledC} 1992 Wiley‐Liss, Inc.",
keywords = "1‐deoxymannojirimycin, Asn‐linked glycan, blood group A antigen, pancreatic cancer cell line, swainsonine",
author = "Masahiko Hirota and Masatoshi Mogaki and Pour, {Parviz M.} and Chaney, {William G}",
year = "1992",
month = "1",
day = "1",
doi = "10.1002/jcb.240500105",
language = "English (US)",
volume = "50",
pages = "13--20",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Modification of blood group A antigen expression in a pancreatic cancer cell line (PC‐1) by inhibitors of N‐glycan processing

AU - Hirota, Masahiko

AU - Mogaki, Masatoshi

AU - Pour, Parviz M.

AU - Chaney, William G

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Pancreatic adenocarcinomas induced in Syrian hamsters by treatment with N‐nitrosobis(2‐oxopropyl) amine express blood group A antigen, which is absent in normal pancreatic cells. On membrane glycoproteins purified from tumors, blood group A antigen has been found to be expressed on multiantennary Asn‐linked complex glycans. In this study, we investigated the effect of inhibitors of Asn‐glycan processing on blood group A antigen bearing glycan structures in a cell line (PC‐1) established from a primary induced pancreatic cancer. Expression of blood group A antigen on cells and in membrane preparations was blocked by treatment with 1‐deoxymannojirimycin, an inhibitor of mannosidase I, but was retained after treatment with swainsonine, an inhibitor of mannosidase II. However, swainsonine treatment altered the glycan structure associated with blood group A antigen from an endoglycosidase H resistant type to a sensitive type, indicating that the blood group A structure might shift from a complex type to a hybr‐id type glycan by this treatment. These results demonstrate that Asn‐linked glycans carry the major blood group A antigens in PC‐1 cells. © 1992 Wiley‐Liss, Inc.

AB - Pancreatic adenocarcinomas induced in Syrian hamsters by treatment with N‐nitrosobis(2‐oxopropyl) amine express blood group A antigen, which is absent in normal pancreatic cells. On membrane glycoproteins purified from tumors, blood group A antigen has been found to be expressed on multiantennary Asn‐linked complex glycans. In this study, we investigated the effect of inhibitors of Asn‐glycan processing on blood group A antigen bearing glycan structures in a cell line (PC‐1) established from a primary induced pancreatic cancer. Expression of blood group A antigen on cells and in membrane preparations was blocked by treatment with 1‐deoxymannojirimycin, an inhibitor of mannosidase I, but was retained after treatment with swainsonine, an inhibitor of mannosidase II. However, swainsonine treatment altered the glycan structure associated with blood group A antigen from an endoglycosidase H resistant type to a sensitive type, indicating that the blood group A structure might shift from a complex type to a hybr‐id type glycan by this treatment. These results demonstrate that Asn‐linked glycans carry the major blood group A antigens in PC‐1 cells. © 1992 Wiley‐Liss, Inc.

KW - 1‐deoxymannojirimycin

KW - Asn‐linked glycan

KW - blood group A antigen

KW - pancreatic cancer cell line

KW - swainsonine

UR - http://www.scopus.com/inward/record.url?scp=0026657026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026657026&partnerID=8YFLogxK

U2 - 10.1002/jcb.240500105

DO - 10.1002/jcb.240500105

M3 - Article

VL - 50

SP - 13

EP - 20

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 1

ER -